Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check19 days agoChange DetectedThe page has updated its date references, removing older dates and adding new ones for June 2025.SummaryDifference0.6%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1.0%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check76 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed information about a phase II trial for nivolumab and BMS986205 in treating head and neck squamous cell carcinoma, while adding new collaborators and a revision number.SummaryDifference40%
Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.